SMARCA4 and lung cancer: The potential impact of BRG1-KO and the resulting broad gene expression and epigenetic changes in sensitizing lung cancer cells to epigenetic therapy were screened using a library of 152 epigenetic drugs against BRG1-WT and KO Calu6 lines.